No anxiety medication is specifically designed to cause weight loss, but one stands out: bupropion is the only antidepressant with a consistently demonstrated weight loss effect. It’s often prescribed off-label for anxiety alongside depression, and at six months, users lost about a quarter pound on average while users of other common medications gained one to three pounds. Beyond bupropion, a few other medications used in anxiety treatment can reduce appetite in the short term, though the picture gets more complicated over time.
Bupropion: The Closest Thing to a Weight-Loss Antidepressant
Bupropion works differently from most anxiety and depression medications. Rather than targeting serotonin like SSRIs do, it increases the activity of dopamine and noradrenaline in the brain. This matters for weight because dopamine plays a central role in the reward system that drives cravings for calorie-rich, highly palatable food. By changing how that reward circuit operates, bupropion reduces the pull toward emotional or pleasure-driven eating.
In a large comparison of eight commonly prescribed antidepressants, bupropion users gained 0.22 kg less than sertraline users over six months and were 15% less likely to gain 5% or more of their starting body weight. Harvard Health data showed bupropion was associated with about a quarter-pound loss at six months, while escitalopram users gained 1.4 pounds, paroxetine users gained 1.4 pounds, and duloxetine users gained 1.2 pounds in the same timeframe.
There’s an important caveat. By 24 months, bupropion users had gained an average of 1.2 pounds. That’s still less than most alternatives (escitalopram reached 3.6 pounds, sertraline 3.2 pounds), but the initial weight loss trend does reverse over time. Bupropion is not FDA-approved specifically for generalized anxiety disorder, though it is commonly prescribed when anxiety co-occurs with depression or when weight concerns make SSRIs a poor fit.
Fluoxetine: Short-Term Loss, Long-Term Reversal
Fluoxetine, the SSRI best known as Prozac, has a reputation for causing early weight loss. Across 11 studies, obese patients taking fluoxetine lost an average of 3.3 kg (about 7.25 pounds) over roughly 28 weeks. That’s a meaningful number in the short term, and it happens because serotonin-based medications reduce impulsive eating during the first weeks and months of treatment.
The problem is that this effect doesn’t last. At 12 months, fluoxetine showed no significant weight loss benefit over placebo. Patients who initially lost weight generally regained it all within a year of stopping the medication. The biology behind this is a receptor called 5-HT2C, which suppresses appetite when it’s active. SSRIs stimulate this receptor early on, but prolonged use causes the receptor to become less responsive. As it downregulates, the appetite-suppressing effect fades, and weight creeps back to (or sometimes beyond) where it started.
This biphasic pattern, where you lose weight for a few months and then gradually gain it back, is common across SSRIs. It’s not unique to fluoxetine, but fluoxetine tends to show the most pronounced early loss, which is why it gets mentioned most often in this context.
How Other Common Anxiety Medications Compare
Most medications prescribed for anxiety cause some degree of weight gain, but the amount varies significantly. Using sertraline as a baseline (about half a pound gained at six months), the differences break down like this:
- Escitalopram: 0.41 kg more than sertraline at six months, reaching 3.6 pounds gained by two years
- Paroxetine: 0.37 kg more than sertraline at six months, reaching 2.9 pounds by two years
- Duloxetine: 0.34 kg more than sertraline at six months, reaching 1.7 pounds by two years
- Venlafaxine: 0.17 kg more than sertraline at six months
- Citalopram: 0.12 kg more than sertraline at six months
None of these cause weight loss. If avoiding weight gain is a priority, sertraline and bupropion sit at the lower end of the spectrum, while paroxetine and escitalopram tend toward the higher end.
Vilazodone, a newer medication, has shown a lower risk of weight gain compared to older antidepressants in a 2024 meta-analysis. It’s not associated with weight loss, but it may be an option for people concerned about gaining weight on treatment.
Topiramate: An Off-Label Option
Topiramate is an anti-seizure medication sometimes prescribed off-label for anxiety, particularly when it co-occurs with binge eating or migraine. It causes more substantial weight loss than any antidepressant. In a 14-week trial, patients taking topiramate lost an average of 5.9 kg (about 13 pounds), compared to just 1.2 kg in the placebo group.
The mechanism isn’t fully understood, but topiramate appears to act as an appetite suppressant or satiety enhancer, making you feel full sooner and reducing the urge to overeat. It’s not a first-line anxiety treatment, and it comes with its own side effects, including cognitive slowing and tingling in the hands and feet. But for people whose anxiety overlaps with compulsive eating, it addresses both problems simultaneously.
Why Early Weight Loss Often Reverses
If you’ve noticed a pattern in the research above, it’s intentional. Nearly every psychiatric medication that causes initial weight loss eventually stops doing so. The brain adapts to the chemical changes these drugs produce. With SSRIs, the appetite-suppressing receptors downregulate. With bupropion, the effect is more durable but still fades by the two-year mark.
This means that choosing an anxiety medication primarily for its weight loss potential is a strategy with a short shelf life. The more reliable goal is finding a medication that treats your anxiety effectively without causing significant weight gain. Bupropion and sertraline are the strongest candidates on that front. Fluoxetine may offer a few months of appetite reduction, but you should expect your weight to return to baseline with continued use.
Weight changes on psychiatric medication also depend on factors beyond the drug itself. Anxiety reduction can change eating patterns in either direction. Some people eat less when they’re no longer stress-eating. Others find that as their mood improves and they become more social, they eat more. The medication creates a chemical nudge, but your overall lifestyle, sleep, and activity level still drive most of the outcome.